Matches in Nanopublications for { ?s ?p "[before RRBSO and with no clinical signs of ovarian cancer) CA125 level was 9.0 U/ml (range 2-78) and was 10.0 U/ml (range 1-43) in 115 BRCA2 mutation carriers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 12 of
12
with 100 items per page.
- NP273177.RATn7v_o7op6f8cF9O2pbxdo4fdIbWKMTY0NkaxhsTY_Q130_assertion description "[before RRBSO and with no clinical signs of ovarian cancer) CA125 level was 9.0 U/ml (range 2-78) and was 10.0 U/ml (range 1-43) in 115 BRCA2 mutation carriers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP273177.RATn7v_o7op6f8cF9O2pbxdo4fdIbWKMTY0NkaxhsTY_Q130_provenance.
- NP542745.RAQGjvwgUH6npqeLP6xrYRCrPD1x3mpW8pX9AC68wHNwQ130_assertion description "[before RRBSO and with no clinical signs of ovarian cancer) CA125 level was 9.0 U/ml (range 2-78) and was 10.0 U/ml (range 1-43) in 115 BRCA2 mutation carriers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP542745.RAQGjvwgUH6npqeLP6xrYRCrPD1x3mpW8pX9AC68wHNwQ130_provenance.
- NP962781.RAbFCvSsj204nf3vjY7XD6X1jq_wMoXK8hnsevGN5o1mI130_assertion description "[before RRBSO and with no clinical signs of ovarian cancer) CA125 level was 9.0 U/ml (range 2-78) and was 10.0 U/ml (range 1-43) in 115 BRCA2 mutation carriers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP962781.RAbFCvSsj204nf3vjY7XD6X1jq_wMoXK8hnsevGN5o1mI130_provenance.
- NP1141839.RACg8Xl0IqI3hBARaogeGqvv9Vt2q9nT2j3ks7yR72y9k130_assertion description "[before RRBSO and with no clinical signs of ovarian cancer) CA125 level was 9.0 U/ml (range 2-78) and was 10.0 U/ml (range 1-43) in 115 BRCA2 mutation carriers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1141839.RACg8Xl0IqI3hBARaogeGqvv9Vt2q9nT2j3ks7yR72y9k130_provenance.
- NP542817.RAioZKXYOw4eNZGCam0Y3_2FzYg5u0xAL8jf02n-7fzOs130_assertion description "[before RRBSO and with no clinical signs of ovarian cancer) CA125 level was 9.0 U/ml (range 2-78) and was 10.0 U/ml (range 1-43) in 115 BRCA2 mutation carriers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP542817.RAioZKXYOw4eNZGCam0Y3_2FzYg5u0xAL8jf02n-7fzOs130_provenance.
- NP273570.RAqk2DgCyUTnPpY1gzIsvjtWpnRK7XJbY0gF-OnDIJXV8130_assertion description "[before RRBSO and with no clinical signs of ovarian cancer) CA125 level was 9.0 U/ml (range 2-78) and was 10.0 U/ml (range 1-43) in 115 BRCA2 mutation carriers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP273570.RAqk2DgCyUTnPpY1gzIsvjtWpnRK7XJbY0gF-OnDIJXV8130_provenance.
- NP962686.RAmXH8P3ZBkE3-RMkOwiELcgvc9A4Pm-fetVf_BSspEV0130_assertion description "[before RRBSO and with no clinical signs of ovarian cancer) CA125 level was 9.0 U/ml (range 2-78) and was 10.0 U/ml (range 1-43) in 115 BRCA2 mutation carriers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP962686.RAmXH8P3ZBkE3-RMkOwiELcgvc9A4Pm-fetVf_BSspEV0130_provenance.
- NP1141840.RAsc7IG4IAL1FtfzOGTkecMP9tVMGhTH5_peS9042llo4130_assertion description "[before RRBSO and with no clinical signs of ovarian cancer) CA125 level was 9.0 U/ml (range 2-78) and was 10.0 U/ml (range 1-43) in 115 BRCA2 mutation carriers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1141840.RAsc7IG4IAL1FtfzOGTkecMP9tVMGhTH5_peS9042llo4130_provenance.
- NP1141837.RAOsk3mSOedbUnmFue0FmuUhmMTL_VmFiH-9La2x0liys130_assertion description "[before RRBSO and with no clinical signs of ovarian cancer) CA125 level was 9.0 U/ml (range 2-78) and was 10.0 U/ml (range 1-43) in 115 BRCA2 mutation carriers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1141837.RAOsk3mSOedbUnmFue0FmuUhmMTL_VmFiH-9La2x0liys130_provenance.
- NP1141841.RAI8aXSTirKCbF91zlFq7Nc0oVT2vYX2MDy28qbj0HNUg130_assertion description "[before RRBSO and with no clinical signs of ovarian cancer) CA125 level was 9.0 U/ml (range 2-78) and was 10.0 U/ml (range 1-43) in 115 BRCA2 mutation carriers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1141841.RAI8aXSTirKCbF91zlFq7Nc0oVT2vYX2MDy28qbj0HNUg130_provenance.
- NP1141835.RA__rWPcn8E4gImkwPrJvajfJlTCKt4fz1zZcpVxSEQLA130_assertion description "[before RRBSO and with no clinical signs of ovarian cancer) CA125 level was 9.0 U/ml (range 2-78) and was 10.0 U/ml (range 1-43) in 115 BRCA2 mutation carriers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1141835.RA__rWPcn8E4gImkwPrJvajfJlTCKt4fz1zZcpVxSEQLA130_provenance.
- NP1141836.RA9lD1aW4aVYhiV4EeZyH_u5RH-GTExL2utSdAnHUDVuM130_assertion description "[before RRBSO and with no clinical signs of ovarian cancer) CA125 level was 9.0 U/ml (range 2-78) and was 10.0 U/ml (range 1-43) in 115 BRCA2 mutation carriers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1141836.RA9lD1aW4aVYhiV4EeZyH_u5RH-GTExL2utSdAnHUDVuM130_provenance.